位置:首页 > 蛋白库 > UVRAG_HUMAN
UVRAG_HUMAN
ID   UVRAG_HUMAN             Reviewed;         699 AA.
AC   Q9P2Y5; B3KTC1; O00392;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=UV radiation resistance-associated gene protein;
DE   AltName: Full=p63;
GN   Name=UVRAG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9169138; DOI=10.1006/geno.1997.4623;
RA   Perelman B., Dafni N., Naiman T., Eli D., Yaakov M., Feng T.L.Y., Sinha S.,
RA   Weber G., Khodaei S., Sancar A., Dotan I., Canaani D.;
RT   "Molecular cloning of a novel human gene encoding a 63-kDa protein and its
RT   sublocalization within the 11q13 locus.";
RL   Genomics 41:397-405(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND POSSIBLE
RP   INVOLVEMENT IN HETEROTAXY.
RC   TISSUE=Heart;
RX   PubMed=10798355; DOI=10.1007/s004390051038;
RA   Iida A., Emi M., Matsuoka R., Hiratsuka E., Okui K., Ohashi H., Inazawa J.,
RA   Fukushima Y., Imai T., Nakamura Y.;
RT   "Identification of a gene disrupted by inv(11)(q13.5;q25) in a patient with
RT   left-right axis malformation.";
RL   Hum. Genet. 106:277-287(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   ASSOCIATION WITH THE PI3K COMPLEX, AND FUNCTION.
RX   PubMed=16799551; DOI=10.1038/ncb1426;
RA   Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., Jung J.U.;
RT   "Autophagic and tumour suppressor activity of a novel Beclin1-binding
RT   protein UVRAG.";
RL   Nat. Cell Biol. 8:688-699(2006).
RN   [6]
RP   INTERACTION WITH SH3GLB1.
RX   PubMed=17891140; DOI=10.1038/ncb1634;
RA   Takahashi Y., Coppola D., Matsushita N., Cualing H.D., Sun M., Sato Y.,
RA   Liang C., Jung J.U., Cheng J.Q., Mule J.J., Pledger W.J., Wang H.G.;
RT   "Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and
RT   tumorigenesis.";
RL   Nat. Cell Biol. 9:1142-1151(2007).
RN   [7]
RP   INTERACTION WITH BECN1 AND PIK3C3, AND SUBCELLULAR LOCATION.
RX   PubMed=18843052; DOI=10.1091/mbc.e08-01-0080;
RA   Itakura E., Kishi C., Inoue K., Mizushima N.;
RT   "Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with
RT   mammalian Atg14 and UVRAG.";
RL   Mol. Biol. Cell 19:5360-5372(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   FUNCTION, INTERACTION WITH VPS16; VPS11; VPS18; VPS33 AND VPS39, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=18552835; DOI=10.1038/ncb1740;
RA   Liang C., Lee J.S., Inn K.S., Gack M.U., Li Q., Roberts E.A., Vergne I.,
RA   Deretic V., Feng P., Akazawa C., Jung J.U.;
RT   "Beclin1-binding UVRAG targets the class C Vps complex to coordinate
RT   autophagosome maturation and endocytic trafficking.";
RL   Nat. Cell Biol. 10:776-787(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-518, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   INTERACTION WITH BECN1.
RX   PubMed=19050071; DOI=10.1073/pnas.0810452105;
RA   Sun Q., Fan W., Chen K., Ding X., Chen S., Zhong Q.;
RT   "Identification of Barkor as a mammalian autophagy-specific factor for
RT   Beclin 1 and class III phosphatidylinositol 3-kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:19211-19216(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498 AND SER-571, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   INTERACTION WITH BECN1; RUBCN; PIK3C3 AND PIK3R4.
RX   PubMed=19270696; DOI=10.1038/ncb1846;
RA   Matsunaga K., Saitoh T., Tabata K., Omori H., Satoh T., Kurotori N.,
RA   Maejima I., Shirahama-Noda K., Ichimura T., Isobe T., Akira S., Noda T.,
RA   Yoshimori T.;
RT   "Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate
RT   autophagy at different stages.";
RL   Nat. Cell Biol. 11:385-396(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-518, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=20643123; DOI=10.1016/j.yexcr.2010.07.008;
RA   Thoresen S.B., Pedersen N.M., Liestol K., Stenmark H.;
RT   "A phosphatidylinositol 3-kinase class III sub-complex containing VPS15,
RT   VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative
RT   endocytic traffic.";
RL   Exp. Cell Res. 316:3368-3378(2010).
RN   [16]
RP   INTERACTION WITH RAB7A.
RX   PubMed=20974968; DOI=10.1073/pnas.1010554107;
RA   Sun Q., Westphal W., Wong K.N., Tan I., Zhong Q.;
RT   "Rubicon controls endosome maturation as a Rab7 effector.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:19338-19343(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   FUNCTION, INTERACTION WITH PRKDC; XRCC6; XRCC5 AND CEP63, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=22542840; DOI=10.1016/j.devcel.2011.12.027;
RA   Zhao Z., Oh S., Li D., Ni D., Pirooz S.D., Lee J.H., Yang S., Lee J.Y.,
RA   Ghozalli I., Costanzo V., Stark J.M., Liang C.;
RT   "A dual role for UVRAG in maintaining chromosomal stability independent of
RT   autophagy.";
RL   Dev. Cell 22:1001-1016(2012).
RN   [19]
RP   INTERACTION WITH SCOC AND FEZ1.
RX   PubMed=22354037; DOI=10.1038/emboj.2012.36;
RA   McKnight N.C., Jefferies H.B., Alemu E.A., Saunders R.E., Howell M.,
RA   Johansen T., Tooze S.A.;
RT   "Genome-wide siRNA screen reveals amino acid starvation-induced autophagy
RT   requires SCOC and WAC.";
RL   EMBO J. 31:1931-1946(2012).
RN   [20]
RP   INTERACTION WITH SLAMF1.
RX   PubMed=22493499; DOI=10.1074/jbc.m112.367060;
RA   Ma C., Wang N., Detre C., Wang G., O'Keeffe M., Terhorst C.;
RT   "Receptor signaling lymphocyte-activation molecule family 1 (Slamf1)
RT   regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting
RT   a Beclin-1/Vps34/ultraviolet radiation resistance-associated gene (UVRAG)
RT   complex.";
RL   J. Biol. Chem. 287:18359-18365(2012).
RN   [21]
RP   INTERACTION WITH BECN1P1/BECN2.
RX   PubMed=23954414; DOI=10.1016/j.cell.2013.07.035;
RA   He C., Wei Y., Sun K., Li B., Dong X., Zou Z., Liu Y., Kinch L.N., Khan S.,
RA   Sinha S., Xavier R.J., Grishin N.V., Xiao G., Eskelinen E.L., Scherer P.E.,
RA   Whistler J.L., Levine B.;
RT   "Beclin 2 functions in autophagy, degradation of G protein-coupled
RT   receptors, and metabolism.";
RL   Cell 154:1085-1099(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498; THR-518; SER-550 AND
RP   SER-689, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   INTERACTION WITH BECN1.
RX   PubMed=23878393; DOI=10.1128/mcb.00079-13;
RA   Fogel A.I., Dlouhy B.J., Wang C., Ryu S.W., Neutzner A., Hasson S.A.,
RA   Sideris D.P., Abeliovich H., Youle R.J.;
RT   "Role of membrane association and Atg14-dependent phosphorylation in
RT   beclin-1-mediated autophagy.";
RL   Mol. Cell. Biol. 33:3675-3688(2013).
RN   [24]
RP   FUNCTION, INTERACTION WITH RINT1, SUBCELLULAR LOCATION, ASSOCIATION WITH
RP   THE PI3K COMPLEX, AND ASSOCIATION WITH THE NRZ COMPLEX.
RX   PubMed=24056303; DOI=10.1038/ncb2848;
RA   He S., Ni D., Ma B., Lee J.H., Zhang T., Ghozalli I., Pirooz S.D., Zhao Z.,
RA   Bharatham N., Li B., Oh S., Lee W.H., Takahashi Y., Wang H.G.,
RA   Minassian A., Feng P., Deretic V., Pepperkok R., Tagaya M., Yoon H.S.,
RA   Liang C.;
RT   "PtdIns(3)P-bound UVRAG coordinates Golgi-ER retrograde and Atg9 transport
RT   by differential interactions with the ER tether and the beclin 1 complex.";
RL   Nat. Cell Biol. 15:1206-1219(2013).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH STX7; VTI1B AND STX8.
RX   PubMed=24550300; DOI=10.1073/pnas.1320629111;
RA   Pirooz S.D., He S., Zhang T., Zhang X., Zhao Z., Oh S., O'Connell D.,
RA   Khalilzadeh P., Amini-Bavil-Olyaee S., Farzan M., Liang C.;
RT   "UVRAG is required for virus entry through combinatorial interaction with
RT   the class C-Vps complex and SNAREs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:2716-2721(2014).
RN   [27]
RP   PHOSPHORYLATION AT SER-493; SER-498; SER-508; SER-522; SER-549; SER-550 AND
RP   SER-582, INTERACTION WITH RUBCN; VPS39; VPS16 AND RAB7A, AND MUTAGENESIS OF
RP   SER-498.
RX   PubMed=25533187; DOI=10.1016/j.molcel.2014.11.013;
RA   Kim Y.M., Jung C.H., Seo M., Kim E.K., Park J.M., Bae S.S., Kim D.H.;
RT   "mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and
RT   endosome maturation.";
RL   Mol. Cell 57:207-218(2015).
RN   [28]
RP   FUNCTION, INTERACTION WITH RUBCNL/PACER, AND SUBCELLULAR LOCATION.
RX   PubMed=28306502; DOI=10.1016/j.molcel.2017.02.010;
RA   Cheng X., Ma X., Ding X., Li L., Jiang X., Shen Z., Chen S., Liu W.,
RA   Gong W., Sun Q.;
RT   "Pacer mediates the function of class III PI3K and HOPS complexes in
RT   autophagosome maturation by engaging Stx17.";
RL   Mol. Cell 65:1029-1043(2017).
CC   -!- FUNCTION: Versatile protein that is involved in regulation of different
CC       cellular pathways implicated in membrane trafficking. Involved in
CC       regulation of the COPI-dependent retrograde transport from Golgi and
CC       the endoplasmic reticulum by associating with the NRZ complex; the
CC       function is dependent on its binding to phosphatidylinositol 3-
CC       phosphate (PtdIns(3)P) (PubMed:16799551, PubMed:18552835,
CC       PubMed:20643123, PubMed:24056303, PubMed:28306502). During autophagy
CC       acts as regulatory subunit of the alternative PI3K complex II (PI3KC3-
CC       C2) that mediates formation of phosphatidylinositol 3-phosphate and is
CC       believed to be involved in maturation of autophagosomes and
CC       endocytosis. Activates lipid kinase activity of PIK3C3
CC       (PubMed:16799551, PubMed:20643123, PubMed:24056303, PubMed:28306502).
CC       Involved in the regulation of degradative endocytic trafficking and
CC       cytokinesis, and in regulation of ATG9A transport from the Golgi to the
CC       autophagosome; the functions seems to implicate its association with
CC       PI3KC3-C2 (PubMed:16799551, PubMed:20643123, PubMed:24056303). Involved
CC       in maturation of autophagosomes and degradative endocytic trafficking
CC       independently of BECN1 but depending on its association with a class C
CC       Vps complex (possibly the HOPS complex); the association is also
CC       proposed to promote autophagosome recruitment and activation of Rab7
CC       and endosome-endosome fusion events (PubMed:18552835, PubMed:28306502).
CC       Enhances class C Vps complex (possibly HOPS complex) association with a
CC       SNARE complex and promotes fusogenic SNARE complex formation during
CC       late endocytic membrane fusion (PubMed:24550300). In case of negative-
CC       strand RNA virus infection is required for efficient virus entry,
CC       promotes endocytic transport of virions and is implicated in a VAMP8-
CC       specific fusogenic SNARE complex assembly (PubMed:24550300).
CC       {ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:20643123,
CC       ECO:0000269|PubMed:24056303, ECO:0000269|PubMed:28306502, ECO:0000305}.
CC   -!- FUNCTION: Involved in maintaining chromosomal stability. Promotes DNA
CC       double-strand break (DSB) repair by association with DNA-dependent
CC       protein kinase complex DNA-PK and activating it in non-homologous end
CC       joining (NHEJ) (PubMed:22542840). Required for centrosome stability and
CC       proper chromosome segregation (PubMed:22542840).
CC       {ECO:0000269|PubMed:22542840}.
CC   -!- SUBUNIT: Component of the PI3K (PI3KC3/PI3K-III/class III
CC       phosphatidylinositol 3-kinase) complex II (PI3KC3-C2) in which the core
CC       composed of the catalytic subunit PIK3C3, the regulatory subunit PIK3R4
CC       and BECN1 is associated with UVRAG; in the complex interacts directly
CC       with BECN1. PI3KC3-C2 can associate with further regulatory subunits
CC       such as RUBCN and probably SH3GLB1/Bif-1 (PubMed:16799551,
CC       PubMed:18843052, PubMed:19050071, PubMed:19270696, PubMed:20643123,
CC       PubMed:23878393, PubMed:24056303). Interacts with SH3GLB1; UVRAG
CC       bridges the interaction to BECN1 indicative for an association with the
CC       PI3K complex PI3KC3-C2 (PubMed:17891140). Interacts with RINT1.
CC       Associates with the NRZ complex under basal conditions and dissociates
CC       from it under autophagy conditions to associate with the PI3K complex;
CC       these complex associations seem to be mutually exclusive
CC       (PubMed:24056303). Interacts with VPS16; VPS11; VPS18; VPS33 (VPS33A or
CC       VPS33B) and VPS39; indicative for an association with a class C Vps
CC       tethering complex (possibly the HOPS complex) (PubMed:18552835,
CC       PubMed:25533187). Interacts with RAB7A; RAB7A competes with UVRAG for
CC       RUBCN binding (PubMed:25533187, PubMed:20974968). Interacts with STX7,
CC       VTI1B, STX8 (PubMed:24550300). Interacts with PRKDC, XRCC6 and XRCC5;
CC       indicative for an association with the DNA-dependent protein kinase
CC       complex DNA-PK. Interacts with CEP63 (PubMed:22542840). Directly
CC       interacts with FEZ1 and SCOC; the interaction with SCOC is reduced by
CC       amino acid starvation, but the complex is stabilized in the presence of
CC       FEZ1 (PubMed:22354037). Interacts with BECN1P1/BECN2 (PubMed:23954414).
CC       Interacts with SLAMF1 (PubMed:22493499). Interacts with RUBCNL/PACER;
CC       promoting targeting of UVRAG to autophagosome (PubMed:28306502).
CC       {ECO:0000269|PubMed:16799551, ECO:0000269|PubMed:17891140,
CC       ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:18843052,
CC       ECO:0000269|PubMed:19050071, ECO:0000269|PubMed:19270696,
CC       ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:20974968,
CC       ECO:0000269|PubMed:22354037, ECO:0000269|PubMed:22493499,
CC       ECO:0000269|PubMed:22542840, ECO:0000269|PubMed:23878393,
CC       ECO:0000269|PubMed:23954414, ECO:0000269|PubMed:24056303,
CC       ECO:0000269|PubMed:24550300, ECO:0000269|PubMed:25533187,
CC       ECO:0000269|PubMed:28306502}.
CC   -!- INTERACTION:
CC       Q9P2Y5; Q07812: BAX; NbExp=6; IntAct=EBI-2952704, EBI-516580;
CC       Q9P2Y5; Q14457: BECN1; NbExp=45; IntAct=EBI-2952704, EBI-949378;
CC       Q9P2Y5; Q8NEB9: PIK3C3; NbExp=23; IntAct=EBI-2952704, EBI-1056470;
CC       Q9P2Y5; Q6NUQ1: RINT1; NbExp=18; IntAct=EBI-2952704, EBI-726876;
CC       Q9P2Y5; Q92622: RUBCN; NbExp=9; IntAct=EBI-2952704, EBI-2952709;
CC       Q9P2Y5; Q9Y371: SH3GLB1; NbExp=11; IntAct=EBI-2952704, EBI-2623095;
CC       Q9P2Y5; Q96AX1: VPS33A; NbExp=4; IntAct=EBI-2952704, EBI-2527283;
CC       Q9P2Y5; P0DTC3: 3a; Xeno; NbExp=6; IntAct=EBI-2952704, EBI-25475894;
CC       Q9P2Y5; Q9QUM4: Slamf1; Xeno; NbExp=6; IntAct=EBI-2952704, EBI-7910086;
CC   -!- SUBCELLULAR LOCATION: Late endosome {ECO:0000269|PubMed:18843052}.
CC       Lysosome {ECO:0000269|PubMed:18843052}. Cytoplasmic vesicle,
CC       autophagosome {ECO:0000269|PubMed:28306502}. Early endosome
CC       {ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:18843052}. Endoplasmic
CC       reticulum {ECO:0000269|PubMed:24056303}. Midbody
CC       {ECO:0000269|PubMed:20643123}. Chromosome, centromere
CC       {ECO:0000269|PubMed:22542840}. Note=Colocalizes with RAB9-positive
CC       compartments involved in retrograde transport from late endosomes to
CC       trans-Golgi network. Colocalization with early endosomes is only
CC       partial (PubMed:24056303). Recruited to autophagosome following
CC       interaction with RUBCNL/PACER (PubMed:28306502).
CC       {ECO:0000269|PubMed:24056303, ECO:0000269|PubMed:28306502}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9P2Y5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P2Y5-2; Sequence=VSP_056176;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, lung, kidney and liver.
CC       {ECO:0000269|PubMed:10798355}.
CC   -!- PTM: Phosphorylated at Ser-498 by MTOR under basal conditions;
CC       increases the interaction with RUBCN implicated in inhibitory effect of
CC       RUBCN on PI3KC3 and decreases interaction with RAB7,A and VPS16 and
CC       VPS39 (indicative for a class C Vps complex, possibly the HOPS complex)
CC       (PubMed:25533187). {ECO:0000269|PubMed:25533187}.
CC   -!- DISEASE: Note=A chromosomal aberration involving UVRAG has been
CC       observed in a patient with heterotaxy (left-right axis malformation).
CC       Inversion Inv(11)(q13.5;q25). {ECO:0000269|PubMed:10798355}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA67507.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X99050; CAA67507.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AB012958; BAA90829.1; -; mRNA.
DR   EMBL; AK095352; BAG53033.1; -; mRNA.
DR   EMBL; AK296871; BAG59434.1; -; mRNA.
DR   EMBL; AK316133; BAH14504.1; -; mRNA.
DR   EMBL; AP002340; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003031; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS8241.1; -. [Q9P2Y5-1]
DR   RefSeq; NP_003360.2; NM_003369.3. [Q9P2Y5-1]
DR   PDB; 7BL1; EM; 9.80 A; AAA=1-699.
DR   PDBsum; 7BL1; -.
DR   AlphaFoldDB; Q9P2Y5; -.
DR   SMR; Q9P2Y5; -.
DR   BioGRID; 113248; 48.
DR   ComplexPortal; CPX-74; Phosphatidylinositol 3-kinase complex, class III, UVRAG variant.
DR   CORUM; Q9P2Y5; -.
DR   DIP; DIP-48652N; -.
DR   IntAct; Q9P2Y5; 59.
DR   MINT; Q9P2Y5; -.
DR   STRING; 9606.ENSP00000348455; -.
DR   ChEMBL; CHEMBL4296018; -.
DR   iPTMnet; Q9P2Y5; -.
DR   PhosphoSitePlus; Q9P2Y5; -.
DR   BioMuta; UVRAG; -.
DR   DMDM; 20140879; -.
DR   EPD; Q9P2Y5; -.
DR   jPOST; Q9P2Y5; -.
DR   MassIVE; Q9P2Y5; -.
DR   MaxQB; Q9P2Y5; -.
DR   PaxDb; Q9P2Y5; -.
DR   PeptideAtlas; Q9P2Y5; -.
DR   PRIDE; Q9P2Y5; -.
DR   ProteomicsDB; 3674; -.
DR   ProteomicsDB; 83914; -. [Q9P2Y5-1]
DR   Antibodypedia; 2165; 440 antibodies from 38 providers.
DR   DNASU; 7405; -.
DR   Ensembl; ENST00000356136.8; ENSP00000348455.3; ENSG00000198382.9. [Q9P2Y5-1]
DR   Ensembl; ENST00000531818.5; ENSP00000434082.1; ENSG00000198382.9. [Q9P2Y5-2]
DR   Ensembl; ENST00000532130.1; ENSP00000436270.1; ENSG00000198382.9. [Q9P2Y5-2]
DR   Ensembl; ENST00000533454.5; ENSP00000431256.1; ENSG00000198382.9. [Q9P2Y5-2]
DR   GeneID; 7405; -.
DR   KEGG; hsa:7405; -.
DR   MANE-Select; ENST00000356136.8; ENSP00000348455.3; NM_003369.4; NP_003360.2.
DR   UCSC; uc001oxc.4; human. [Q9P2Y5-1]
DR   CTD; 7405; -.
DR   DisGeNET; 7405; -.
DR   GeneCards; UVRAG; -.
DR   HGNC; HGNC:12640; UVRAG.
DR   HPA; ENSG00000198382; Low tissue specificity.
DR   MIM; 602493; gene.
DR   neXtProt; NX_Q9P2Y5; -.
DR   OpenTargets; ENSG00000198382; -.
DR   PharmGKB; PA37264; -.
DR   VEuPathDB; HostDB:ENSG00000198382; -.
DR   eggNOG; KOG2896; Eukaryota.
DR   GeneTree; ENSGT00390000012877; -.
DR   HOGENOM; CLU_009375_2_0_1; -.
DR   InParanoid; Q9P2Y5; -.
DR   OMA; XELFLKT; -.
DR   OrthoDB; 1081121at2759; -.
DR   PhylomeDB; Q9P2Y5; -.
DR   TreeFam; TF323546; -.
DR   BRENDA; 2.7.1.137; 2681.
DR   PathwayCommons; Q9P2Y5; -.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-9679504; Translation of Replicase and Assembly of the Replication Transcription Complex.
DR   Reactome; R-HSA-9694676; Translation of Replicase and Assembly of the Replication Transcription Complex.
DR   Reactome; R-HSA-9754560; SARS-CoV-2 modulates autophagy.
DR   SignaLink; Q9P2Y5; -.
DR   SIGNOR; Q9P2Y5; -.
DR   BioGRID-ORCS; 7405; 91 hits in 1086 CRISPR screens.
DR   ChiTaRS; UVRAG; human.
DR   GeneWiki; UVRAG; -.
DR   GenomeRNAi; 7405; -.
DR   Pharos; Q9P2Y5; Tbio.
DR   PRO; PR:Q9P2Y5; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9P2Y5; protein.
DR   Bgee; ENSG00000198382; Expressed in adrenal tissue and 196 other tissues.
DR   ExpressionAtlas; Q9P2Y5; baseline and differential.
DR   Genevisible; Q9P2Y5; HS.
DR   GO; GO:0000421; C:autophagosome membrane; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:CACAO.
DR   GO; GO:0005768; C:endosome; IBA:GO_Central.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0000323; C:lytic vacuole; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0035032; C:phosphatidylinositol 3-kinase complex, class III; IPI:ComplexPortal.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0000149; F:SNARE binding; IBA:GO_Central.
DR   GO; GO:0097352; P:autophagosome maturation; IDA:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IMP:CACAO.
DR   GO; GO:0007098; P:centrosome cycle; IMP:UniProtKB.
DR   GO; GO:0007059; P:chromosome segregation; IEA:Ensembl.
DR   GO; GO:0006281; P:DNA repair; IMP:UniProtKB.
DR   GO; GO:0097680; P:double-strand break repair via classical nonhomologous end joining; IDA:UniProtKB.
DR   GO; GO:0051684; P:maintenance of Golgi location; IMP:CACAO.
DR   GO; GO:0071985; P:multivesicular body sorting pathway; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; IDA:ComplexPortal.
DR   GO; GO:1901098; P:positive regulation of autophagosome maturation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:ComplexPortal.
DR   GO; GO:0032801; P:receptor catabolic process; IMP:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IDA:ComplexPortal.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0071900; P:regulation of protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006890; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; IMP:CACAO.
DR   GO; GO:0035493; P:SNARE complex assembly; IBA:GO_Central.
DR   GO; GO:0007051; P:spindle organization; IEA:Ensembl.
DR   GO; GO:0046718; P:viral entry into host cell; IEA:Ensembl.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR018791; UV_resistance/autophagy_Atg14.
DR   Pfam; PF10186; ATG14; 1.
DR   SMART; SM00239; C2; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   PROSITE; PS50004; C2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Centromere; Chromosome; Coiled coil;
KW   Cytoplasmic vesicle; DNA damage; DNA repair; Endoplasmic reticulum;
KW   Endosome; Lysosome; Phosphoprotein; Reference proteome.
FT   CHAIN           1..699
FT                   /note="UV radiation resistance-associated gene protein"
FT                   /id="PRO_0000065750"
FT   DOMAIN          23..149
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..269
FT                   /note="Sufficient for interaction with STX7; VTI1B AND
FT                   STX8"
FT                   /evidence="ECO:0000269|PubMed:24550300"
FT   REGION          270..442
FT                   /note="Sufficient for interaction with VPS16, required for
FT                   interaction with CEP63"
FT                   /evidence="ECO:0000269|PubMed:18552835,
FT                   ECO:0000269|PubMed:22542840"
FT   REGION          443..699
FT                   /note="Required for interaction with PRKDC, XRCC6 and
FT                   XRCC5"
FT                   /evidence="ECO:0000269|PubMed:22542840"
FT   REGION          486..591
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          224..305
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        513..555
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        576..591
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25533187"
FT   MOD_RES         498
FT                   /note="Phosphoserine; by MTOR"
FT                   /evidence="ECO:0000269|PubMed:25533187,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         508
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25533187"
FT   MOD_RES         518
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25533187"
FT   MOD_RES         549
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25533187"
FT   MOD_RES         550
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25533187,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         571
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25533187"
FT   MOD_RES         689
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..372
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056176"
FT   VARIANT         10
FT                   /note="P -> H (in dbSNP:rs7118567)"
FT                   /id="VAR_059737"
FT   MUTAGEN         498
FT                   /note="S->A: Abolishes phosphorylation by MTOR, decreases
FT                   interaction with RUBCN, increases interaction with VPS16
FT                   and VPS39, promotes autophagosome maturation and endosome-
FT                   lysosomal degradation of EGFR."
FT                   /evidence="ECO:0000269|PubMed:25533187"
SQ   SEQUENCE   699 AA;  78151 MW;  23C4413B10F641BA CRC64;
     MSASASVGGP VPQPPPGPAA ALPPGSAARA LHVELPSQQR RLRHLRNIAA RNIVNRNGHQ
     LLDTYFTLHL CSTEKIYKEF YRSEVIKNSL NPTWRSLDFG IMPDRLDTSV SCFVVKIWGG
     KENIYQLLIE WKVCLDGLKY LGQQIHARNQ NEIIFGLNDG YYGAPFEHKG YSNAQKTILL
     QVDQNCVRNS YDVFSLLRLH RAQCAIKQTQ VTVQKIGKEI EEKLRLTSTS NELKKKSECL
     QLKILVLQNE LERQKKALGR EVALLHKQQI ALQDKGSAFS AEHLKLQLQK ESLNELRKEC
     TAKRELFLKT NAQLTIRCRQ LLSELSYIYP IDLNEHKDYF VCGVKLPNSE DFQAKDDGSI
     AVALGYTAHL VSMISFFLQV PLRYPIIHKG SRSTIKDNIN DKLTEKEREF PLYPKGGEKL
     QFDYGVYLLN KNIAQLRYQH GLGTPDLRQT LPNLKNFMEH GLMVRCDRHH TSSAIPVPKR
     QSSIFGGADV GFSGGIPSPD KGHRKRASSE NERLQYKTPP PSYNSALAQP VTTVPSMGET
     ERKITSLSSS LDTSLDFSKE NKKKGEDLVG SLNGGHANVH PSQEQGEALS GHRATVNGTL
     LPSEQAGSAS VQLPGEFHPV SEAELCCTVE QAEEIIGLEA TGFASGDQLE AFNCIPVDSA
     VAVECDEQVL GEFEEFSRRI YALNENVSSF RRPRRSSDK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024